Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor.

Q2 Pharmacology, Toxicology and Pharmaceutics Antiviral Chemistry and Chemotherapy Pub Date : 2015-02-01 DOI:10.1177/2040206614566580
Ying-Shan Han, Wei-Lie Xiao, Hongtao Xu, Victor G Kramer, Yudong Quan, Thibault Mesplède, Maureen Oliveira, Susan P Colby-Germinario, Han-Dong Sun, Mark A Wainberg
{"title":"Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor.","authors":"Ying-Shan Han,&nbsp;Wei-Lie Xiao,&nbsp;Hongtao Xu,&nbsp;Victor G Kramer,&nbsp;Yudong Quan,&nbsp;Thibault Mesplède,&nbsp;Maureen Oliveira,&nbsp;Susan P Colby-Germinario,&nbsp;Han-Dong Sun,&nbsp;Mark A Wainberg","doi":"10.1177/2040206614566580","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Due to resistance to all classes of anti-HIV drugs and drug toxicity, there is a need for the discovery and development of new anti-HIV drugs.</p><p><strong>Methods: </strong>HIV-1 inhibitors were identified and biologically characterized for mechanism of action.</p><p><strong>Results: </strong>We identified a dibenzocyclooctadiene lignan, termed HDS2 that possessed anti-HIV activity against a wide variety of viral strains with EC50 values in the 1-3 µM range. HDS2 was shown to act as an NNRTI by qPCR and in vitro enzyme assays.</p><p><strong>Conclusions: </strong>This compound provides a new scaffold for further optimization of activity through structure-guided design.</p>","PeriodicalId":7960,"journal":{"name":"Antiviral Chemistry and Chemotherapy","volume":"24 1","pages":"28-38"},"PeriodicalIF":0.0000,"publicationDate":"2015-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2040206614566580","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antiviral Chemistry and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2040206614566580","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 9

Abstract

Background: Due to resistance to all classes of anti-HIV drugs and drug toxicity, there is a need for the discovery and development of new anti-HIV drugs.

Methods: HIV-1 inhibitors were identified and biologically characterized for mechanism of action.

Results: We identified a dibenzocyclooctadiene lignan, termed HDS2 that possessed anti-HIV activity against a wide variety of viral strains with EC50 values in the 1-3 µM range. HDS2 was shown to act as an NNRTI by qPCR and in vitro enzyme assays.

Conclusions: This compound provides a new scaffold for further optimization of activity through structure-guided design.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
二苯并环二烯木脂素作为HIV-1非核苷类逆转录酶抑制剂的鉴定。
背景:由于各类抗hiv药物的耐药性和药物毒性,需要发现和开发新的抗hiv药物。方法:鉴定HIV-1抑制剂并对其作用机制进行生物学表征。结果:我们鉴定了一种名为HDS2的二苯并环二烯木脂素,它对多种病毒株具有抗hiv活性,EC50值在1-3µM范围内。通过qPCR和体外酶分析显示HDS2具有NNRTI的作用。结论:该化合物通过结构导向设计为进一步优化活性提供了新的支架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Antiviral Chemistry and Chemotherapy
Antiviral Chemistry and Chemotherapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
5.20
自引率
0.00%
发文量
5
审稿时长
15 weeks
期刊介绍: Antiviral Chemistry & Chemotherapy publishes the results of original research concerned with the biochemistry, mode of action, chemistry, pharmacology and virology of antiviral compounds. Manuscripts dealing with molecular biology, animal models and vaccines are welcome. The journal also publishes reviews, pointers, short communications and correspondence.
期刊最新文献
The continuing need for therapeutic agents for respiratory syncytial virus infection. The development of BVDU: An odyssey. Meeting report: 34th international conference on antiviral research. Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimens. Reflections on the Rega Institute for Medical Research, at the fiftieth anniversary of the Rega Stichting vzw (Rega Instituut vzw, Rega Foundation).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1